Skip to main content
Premium Trial:

Request an Annual Quote

Daniel Caserza, Matthew Hogan, Gail Page, Stephen Scherer


Daniel Caserza, interim chief financial officer of Ciphergen Biosystems, is expected to resign this week, according to documents filed with the Securities and Exchange Commission. He became the interim CFO in March after Matthew Hogan abruptly resigned.

Gail Page, the company's president and chief executive officer, will act as interim chief financial officer until the company finds a permanent replacement.

Ciphergen has hired the Financial Leadership Group to help it prepare financial statements until a replacement is appointed.

Stephen Scherer has joined CombiMatrix Molecular Diagnostics' science advisory board.

Scherer is a senior scientist in genetics and genomic biology at The Hospital for Sick Children in Canada and associate professor of medicine at the University of Toronto. He is also director of the Centre for Applied Genomics and associate chief of research at the hospital.

CombiMatrix Molecular Diagnostics is wholly owned by CombiMatrix.

Filed under

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.